EBS - Emergent Biosolutions - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart Insider Trading

EBS is currently covered by 6 analysts with an average price target of $14.32. This is a potential upside of $12.4 (645.83%) from yesterday's end of day stock price of $1.92.

Emergent Biosolutions's activity chart (see below) currently has 57 price targets and 54 ratings on display. The stock rating distribution of EBS is 40% HOLD, 46.67% BUY and 13.33% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 57.08% with an average time for these price targets to be met of 104.25 days.

Highest price target for EBS is $15, Lowest price target is $5, average price target is $14.32.

Most recent stock forecast was given by ROBERT WASSERMAN from BENCHMARK on 11-Apr-2024. First documented stock forecast 19-Feb-2016.

Currently out of the existing stock ratings of EBS, 6 are a HOLD (40%), 7 are a BUY (46.67%), 2 are a SELL (13.33%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

5

$2.82 (129.36%)

5

15 days ago

0/5 (0%)

$2.81 (128.31%)

Sell

23

5 months 6 days ago

1/3 (33.33%)

$14.88 (183.25%)

1

Hold

15

$12.82 (588.07%)

29

11 months 7 days ago

4/8 (50%)

$6.83 (83.60%)

86

Buy

55

$52.82 (2422.94%)

65

1 years 5 months 17 days ago

2/8 (25%)

$42.15 (328.02%)

217

Hold

23

$20.82 (955.05%)

33

1 years 5 months 17 days ago

11/15 (73.33%)

$10.15 (78.99%)

166

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is EBS (Emergent Biosolutions) average time for price targets to be met?

On average it took 104.25 days on average for the stock forecasts to be realized with a an average price target met ratio 57.08

Which analyst has the current highest performing score on EBS (Emergent Biosolutions) with a proven track record?

BRANDON FOLKES

Which analyst has the current lower performing score on EBS (Emergent Biosolutions) with a proven track record?

ROBERT WASSERMAN

Which analyst has the most public recommendations on EBS (Emergent Biosolutions)?

Brandon Folkes has 6 price targets and 3 ratings on EBS

Which analyst is the currently most bullish on EBS (Emergent Biosolutions)?

Dana Flanders with highest potential upside - $97.6

Which analyst is the currently most reserved on EBS (Emergent Biosolutions)?

Jessica Fye with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?